China's biggest biotech plots $2B IPO

Citing sources, Bloomberg is reporting that China National Biotec is planning a $2 billion IPO. The company is ranked as the largest biotech in China and the fourth largest vaccine-maker in the world. If all goes according to plan, the company's shares will start trading next year. Report